BCL2A1 and nasopharyngeal carcinoma: The sgBFL-1#1 and sgBFL-1#2 cells were treated with increasing concentrations of either ABT-199 or A1331852 to access whether BFL-1 deletion sensitized NPC cells to these inhibitors.